$VIVS
VivoSim Labs, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$0.170
▼-5.55%-$0.010
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateVivoSim Labs, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is VIVS down today? It is at $0.170 (-5.55%), and our scanner flagged it 18 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment VIVS spikes, and full due diligence on VIVS — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $VIVS 18 times in the last 30 days. Create a free account to track $VIVS, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
VIVS is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 2 unusual-volume and momentum alerts on VIVS today, peaking at 74.0x its normal volume.
Likely catalystExecutive / Board Change · Shareholder VoteReverse split plannedStatus pending stockholder approval, from the latest SEC filing. Read it →A share sale has already completed, so that supply is out there. Size not stated in the filing.
Some filings did not state a size, so these are floors.
Recent priced share offering — a one-time sale that has already completed (not ongoing)
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Lialin Tony Serge Officer | Bought (open market) | +10K 0.07% of company | n/a | 10K | $3K at $0.280 | Aug 31, 26 |
Stern Adam K Director | Acquired (grant/award) | +15K 0.1% of company | added 100% | 20K | n/a | Jan 27, 26 |
Gobel David Director | Acquired (grant/award) | +15K 0.1% of company | n/a | 15K | n/a | Jan 27, 26 |
Milhous Alison Tjosvold Director | Acquired (grant/award) | +15K 0.1% of company | added 100% | 20K | n/a | Jan 27, 26 |
Murphy Keith Officer | Acquired (grant/award) | +15K 0.1% of company | added 100% | 26K | n/a | Jan 27, 26 |
Cohen Douglas Jay Director | Acquired (grant/award) | +15K 0.1% of company | added 100% | 21K | n/a | Jan 27, 26 |
Gobel David Director | Sold (automatic/other) | -3K 0.02% of company | n/a | n/a | $7K at $2.24 | Nov 17, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in biological products, (no diagnostic substances), closest in size first.
VIVS is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 2 unusual-volume and momentum alerts on VIVS today, peaking at 74.0x its normal volume.
VIVS last traded at $0.170, down 5.55% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
VivoSim Labs, Inc. Common Stock (VIVS) is next expected to report earnings on Thursday, November 5, 2026, about 24 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The VIVS Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged VIVS 18 times in the last 30 days.
VIVS (VivoSim Labs, Inc. Common Stock) trades on XNAS, with a market cap of about $3M in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge VIVS for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$VIVS discussion
Sign in to ask a question or join the discussion.